Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1529599

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1529599

AI In Patient Engagement Market Size, Share & Trends Analysis Report By Technology, By Delivery Type, By Functionality, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

AI In Patient Engagement Market Growth & Trends:

The global AI in patient engagement market size is expected to reach USD 23.1 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing demand for AI-based personalized treatment plans and healthcare experiences and the emergence of digital platforms and necessity for omnichannel approach. In addition, the increasing role of artificial intelligence (AI) in enhancing pharmacy efficiency and managing supply chain complexities and business strategies by market players is also driving the market growth. For instance, in May 2024, EmpiRx Health introduced Clinically, a new AI-powered platform that incorporates established technologies. This platform enhances pharmacy claims processing and clinical evaluations and includes a unique population health engine, reinforcing EmpiRx Health's clinical-focused Pharmacy Benefit Management (PBM) approach.

Moreover, the growing prevalence of chronic diseases, such as diabetes and hypertension, necessitates continuous patient engagement & management, which AI can effectively facilitate. Furthermore, AI technologies such as machine learning and natural language processing (NLP) can significantly enhance patient engagement by providing personalized support & interventions. These technologies analyze patient data to offer tailored recommendations, reminders, & educational content, improving adherence and health outcomes. For instance, in March 2022, Uniphore entered into a strategic partnership with SpinSci Technologies, a provider of digital patient engagement solutions, to improve patient access and interaction with healthcare providers. This collaboration integrated Uniphore's conversational AI and automation technology into SpinSci Technologies Patient Access Care solutions, which are compatible with Electronic Health Records (EHR) systems. The integration aimed to enhance efficiency for contact center agents and streamline patient self-service workflows.

The integration of AI enables healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

In addition, the market in North America is driven by the integration of AI, enabling healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

AI In Patient Engagement Market Report Highlights:

  • On the basis of delivery mode, the cloud-based segment dominated the market and held a revenue share of 72.37% in 2023. Cloud-based solutions provide scalable resources, enabling healthcare organizations to adjust capacity according to demand fluctuations
  • On the basis of functionality, enhanced communication held the largest revenue share of 25.84% in 2023. The growing integration of AI-driven solutions in the healthcare sector is driving the need for enhanced communication capabilities
  • On the basis of technology, Natural Language Processing (NLP) held the largest revenue share of 88.82% in 2023. The segment growth can be attributed to several benefits offered by NLP models such as improved patient engagement and education through the provision of tailored & comprehensible health information
  • On the basis of therapeutic area, chronic disease management held the largest revenue share of 64.87% in 2023. The segment growth can be attributed to the increasing prevalence of chronic conditions such as diabetes, hypertension, and heart disease
  • On the basis of end use, the healthcare providers segment held the largest revenue share of 38.31% in 2023. The increasing focus on patient-centric care, coupled with the growing need for effective use of resources and a rising demand for personalized healthcare experiences, is driving healthcare providers to adopt AI for patient engagement
  • North America dominated the market with a share of 43.60% in 2023. Key factors contributing to this notable share include the presence of a well-established healthcare infrastructure equipped with advanced technology, increasing awareness of the advantages of integrating AI-enabled patient engagement solutions, and a growing preference for personalized healthcare experiences & treatment plans
  • The market is fragmented owing to the presence of several players. This is expected to intensify the competition in the coming years. Key companies are increasingly adopting strategies such as new product development, collaborations, and mergers & acquisitions to strengthen their market position. In June 2024, MedAdvisor Solutions announced the launch of Omnichannel Engagement for Pharmacy powered by THRiV, its AI-enabled platform. This suite enables pharmacies to enhance their digital patient engagement strategies and existing initiatives, including providing paperless options increasingly preferred by patients
Product Code: GVR-4-68040-145-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Therapeutic Area
    • 1.1.3. Functionality
    • 1.1.4. Delivery Type
    • 1.1.5. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology Outlook
    • 2.2.2. Therapeutic Area Outlook
    • 2.2.3. Functionality Outlook
    • 2.2.4. Delivery Outlook
    • 2.2.5. End Use Outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Intelligence (AI) in Patient Engagement Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Artificial Intelligence (AI) in Patient Engagement Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Impact of COVID-19
    • 3.3.4. Case Study

Chapter 4. Artificial Intelligence (AI) in Patient Engagement Market Delivery Type Estimates & Trend Analysis

  • 4.1. Delivery Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Delivery Type Outlook
  • 4.4. Cloud-based
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. On-premise
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence (AI) in Patient Engagement Market Functionality Estimates & Trend Analysis

  • 5.1. Functionality Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Functionality Outlook
  • 5.4. Enhanced Communication
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Patient Education
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Chabot & Virtual Health Assistants
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Predictive Analytics
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Administrative & Streamlined Operations
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence (AI) in Patient Engagement Market Technology Type Estimates & Trend Analysis

  • 6.1. Technology Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Technology Type Outlook
  • 6.4. NLP
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Smart Assistance
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Optical Character Recognition (OCR)
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.4. Auto Coding
      • 6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.5. Text Analytics
      • 6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.6. Speech Analytics
      • 6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.7. Classification & Categorization
      • 6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence (AI) in Patient Engagement Market Therapeutic Area Estimates & Trend Analysis

  • 7.1. Therapeutic Area Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Therapeutic Area Outlook
  • 7.4. Health & Wellness
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Chronic Disease Management
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Artificial Intelligence (AI) in Patient Engagement Market End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Artificial Intelligence (AI) in Patient Engagement Market by End Use Outlook
  • 8.4. Healthcare Provider
    • 8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5. Healthcare Payers
    • 8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Pharmaceutical Companies
      • 8.6.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 8.6.2. Pharmacy
      • 8.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Artificial Intelligence (AI) in Patient Engagement Market Regional Estimates & Trend Analysis, By Component, By Technology Type

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. Singapore
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Innovators
  • 10.4. Vendor Landscape
    • 10.4.1. Key company market position analysis, 2023
    • 10.4.2. Medadvisor Solutions
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Innovaccer Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. EnlivenHealth (Omnicell)
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. EmpiRx Health
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. IBM.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Huma
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. mPulse Mobile
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. AllazoHealth
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. P360
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Brand Engagement Network, Inc.
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Oracle
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Nuance Communications Inc. (Microsoft)
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Health Catalyst
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Ada Health GmbH
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. Aiva Inc.
      • 10.4.16.1. Company overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Product benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. Claritas Rx
      • 10.4.17.1. Company overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Product benchmarking
      • 10.4.17.4. Strategic initiatives
    • 10.4.18. AiCure
      • 10.4.18.1. Company overview
      • 10.4.18.2. Financial performance
      • 10.4.18.3. Product benchmarking
      • 10.4.18.4. Strategic initiatives
    • 10.4.19. UST Global Inc.
      • 10.4.19.1. Company overview
      • 10.4.19.2. Financial performance
      • 10.4.19.3. Product benchmarking
      • 10.4.19.4. Strategic initiatives
    • 10.4.20. ZS
      • 10.4.20.1. Company overview
      • 10.4.20.2. Financial performance
      • 10.4.20.3. Product benchmarking
      • 10.4.20.4. Strategic initiatives
    • 10.4.21. IQVIA, Inc.
      • 10.4.21.1. Company overview
      • 10.4.21.2. Financial performance
      • 10.4.21.3. Product benchmarking
      • 10.4.21.4. Strategic initiatives
Product Code: GVR-4-68040-145-8

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 4 North America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 5 North America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 7 North America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 9 U.S. AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 10 U.S. AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 12 U.S. AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 15 Canada AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Canada AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 17 Canada AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Mexico AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 19 Mexico AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 20 Mexico AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Mexico AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Mexico AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Europe AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 24 Europe AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 25 Europe AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 26 Europe AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 28 Europe AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 30 Germany AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 31 Germany AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 33 Germany AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 UK AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 35 UK AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 36 UK AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 UK AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 France AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 40 France AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 41 France AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 42 France AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 43 France AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Italy AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 45 Italy AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 46 Italy AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Italy AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 48 Italy AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Spain AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 50 Spain AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 51 Spain AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Spain AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 53 Spain AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Denmark AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 55 Denmark AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 56 Denmark AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 58 Denmark AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Sweden AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 60 Sweden AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 61 Sweden AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 63 Sweden AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Norway AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 65 Norway AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 66 Norway AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Norway AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 68 Norway AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 China AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 76 China AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 77 China AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 78 China AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 79 China AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Japan AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 81 Japan AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 82 Japan AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 84 Japan AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 India AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 86 India AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 87 India AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 88 India AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 89 India AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 South Korea AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 91 South Korea AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 92 South Korea AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 94 South Korea AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Australia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 96 Australia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 97 Australia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 99 Australia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Thailand AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 101 Thailand AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 102 Thailand AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 104 Thailand AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Latin America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 106 Latin America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 107 Latin America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 108 Latin America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 110 Latin America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Brazil AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 112 Brazil AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 113 Brazil AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 115 Brazil AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 Argentina AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 117 Argentina AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 118 Argentina AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Argentina AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 120 Argentina AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 MEA AI in patient engagement market, by region, 2018 - 2030 (USD Million)
  • Table 122 MEA AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 123 MEA AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 124 MEA AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 125 MEA AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 126 MEA AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 South Africa AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 128 South Africa AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 129 South Africa AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 130 South Africa AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 131 South Africa AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 UAE AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 138 UAE AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 139 UAE AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 140 UAE AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 141 UAE AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 143 Kuwait AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
  • Table 144 Kuwait AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
  • Table 145 Kuwait AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 146 Kuwait AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Artificial intelligence in patient engagement market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 AI in Patient Engagement Market Dynamics
  • Fig. 12 Major chatbot use cases in healthcare
  • Fig. 13 Advantages of omnichannel for pharmaceutical industry
  • Fig. 14 Key benefits of patient-centered care:
  • Fig. 15 Key challenges and strategies to maximize the potential of conversational AI in healthcare
  • Fig. 16 AI in patient engagement market: Porter's five forces analysis
  • Fig. 17 AI in patient engagement market: PESTLE analysis
  • Fig. 18 AI in patient engagement market, component outlook key takeaways (USD million)
  • Fig. 19 AI in patient engagement market: Technology movement analysis, 2023 & 2030 (USD Million)
  • Fig. 20 NLP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Smart assistance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 OCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Auto coding market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Speech analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 AI in patient engagement market, therapeutic outlook key takeaways (USD Million)
  • Fig. 29 AI in patient engagement market: Therapeutic area movement analysis, 2023 & 2030 (USD Million)
  • Fig. 30 Health & wellness market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Chronic disease management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 AI in patient engagement market, functionality outlook key takeaways (USD Million)
  • Fig. 34 AI in patient engagement market: Functionality movement analysis, 2023 & 2030 (USD Million)
  • Fig. 35 Enhanced communication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Patient education market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Chatbots and virtual health assistants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Predictive analytics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Administrative and streamlined operations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 AI in patient engagement market, delivery type outlook key takeaways (USD million)
  • Fig. 42 AI in patient engagement market: Delivery type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 43 Cloud-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 AI in patient engagement market, end use outlook key takeaways (USD Million)
  • Fig. 46 AI in patient engagement market: End use movement analysis, 2023 & 2030 (USD Million)
  • Fig. 47 Healthcare providers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Healthcare payers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Regional outlook, 2023 & 2030
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America: SWOT Analysis
  • Fig. 54 North America AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S country dynamics
  • Fig. 56 U.S. AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 57 Canada country dynamics
  • Fig. 58 Canada AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico country dynamics
  • Fig. 60 Mexico AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 61 Europe: SWOT Analysis
  • Fig. 62 Europe AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 63 Germany country dynamics
  • Fig. 64 Germany AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 65 France country dynamics
  • Fig. 66 France AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 67 UK country dynamics
  • Fig. 68 UK AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy country dynamics
  • Fig. 70 Italy AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain country dynamics
  • Fig. 72 Spain AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 73 Denmark country dynamics
  • Fig. 74 Denmark AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 75 Sweden country dynamics
  • Fig. 76 Sweden AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 77 Norway country dynamics
  • Fig. 78 Norway AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific: SWOT Analysis
  • Fig. 80 Asia Pacific AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 81 Japan country dynamics
  • Fig. 82 Japan AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 83 China country dynamics
  • Fig. 84 China AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 85 India country dynamics
  • Fig. 86 India AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 87 Australia country dynamics
  • Fig. 88 Australia AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 89 South Korea country dynamics
  • Fig. 90 South Korea AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand country dynamics
  • Fig. 92 Thailand AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America: SWOT Analysis
  • Fig. 94 Latin America AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil country dynamics
  • Fig. 96 Brazil AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 97 Argentina country dynamics
  • Fig. 98 Argentina AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 99 MEA: SWOT Analysis
  • Fig. 100 MEA AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 101 South Africa country dynamics
  • Fig. 102 South Africa AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 103 Saudi Arabia country dynamics
  • Fig. 104 Saudi Arabia AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 105 UAE country dynamics
  • Fig. 106 UAE AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 107 Kuwait country dynamics
  • Fig. 108 Kuwait AI in patient engagement market, 2018 - 2030 (USD Million)
  • Fig. 109 Key company categorization
  • Fig. 110 Company market position analysis
  • Fig. 111 Strategy mapping
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!